NCT02371629 A Study of the Efficacy and Safety of NVA237 in Patients With Moderate to Severe COPD Status COMPLETED Phase PHASE4
NCT02370706 Study of the Safety of PIM447 in Combination With Ruxolitinib (INC424) and LEE011 in Patients With Myelofibrosis Status COMPLETED Phase PHASE1
NCT02367859 Dabrafenib and Trametinib in Treating Patients With BRAF Mutated Ameloblastoma Status COMPLETED Phase PHASE2
NCT02366468 Study of Efficacy of Ranibizumab in Different Regimens in Patients With Diabetic Macula Edema Status COMPLETED Phase PHASE4
NCT02362789 Secukinumab Study in PSOriasis Exploring pruRITUS Intensity and Lesional Biomarkers Status COMPLETED Phase PHASE3
NCT02354508 Pasireotide in Patients With Acromegaly Inadequately Controlled With First Generation Somatostatin Analogues Status COMPLETED Phase PHASE3
NCT02353728 Stem Cell Monitoring for CML Patients Undergoing Nilotinib Therapy Status COMPLETED Phase PHASE2
NCT02345824 Early-Phase Study to Assess Inhibitor Ribociclib in Patients With Recurrent Glioblastoma or Anaplastic Glioma Status UNKNOWN Phase PHASE1
NCT02343172 Study of Safety and Efficacy of HDM201 in Combination With LEE011 in Patients With Liposarcoma Status COMPLETED Phase PHASE1
NCT02338609 Long-term Monitoring of Growth and Development of Pediatric Patients Previously Treated With Everolimus Status COMPLETED Phase PHASE4
NCT02336451 A Phase II Study to Evaluate the Efficacy and Safety of Oral Ceritinib in Patients With ALK-positive NSCLC Metastatic to the Brain and/or to Leptomeninges Status COMPLETED Phase PHASE2
NCT02336425 Efficacy and Safety of QGE031 Compared With Placebo in Patients Aged 18-75 Years With Asthma Status TERMINATED Phase PHASE2
NCT02335944 Study of Safety and Efficacy of EGFR-TKI EGF816 in Combination With cMET Inhibitor INC280 in Adult Patients With EGFR Mutated Non Small Cell Lung Cancer. Status TERMINATED Phase PHASE1/PHASE2
NCT02335892 PROFILE - Evaluation of QoL and PRO Outcomes in Patients Taking Fingolimod Status COMPLETED Phase N/A
NCT02334748 A Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis or Hereditary Periodic Fevers Who Participated in the CACZ885G2301E1, CACZ885G2306 or CACZ885N2301 Studies Status COMPLETED Phase PHASE3
NCT02334449 First-in-human Study to Assess the Safety and Pharmacokinetics of LML134 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02333370 A Phase Ib Dose Escalation Study of the Combination of LEE011 With Letrozole and Dose Expansion of LEE011 With Hormonal Therapy for the Treatment of Pre-(With Goserelin) and Postmenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer Status COMPLETED Phase PHASE1
NCT02333344 The Efficacy Study of Aclasta on Prosthetic Fixation in Postmenopausal Women After THA Status WITHDRAWN Phase PHASE4